GW & Wade’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-296,652
Closed -$7.04M 442
2023
Q3
$7.04M Buy
296,652
+12,841
+5% +$242K 0.26% 82
2023
Q2
$4.6M Hold
283,811
0.17% 100
2023
Q1
$4.94M Sell
283,811
-2,637
-0.9% -$47.4K 0.19% 96
2022
Q4
$5.38M Buy
286,448
+37,773
+15% +$728K 0.22% 84
2022
Q3
$4.4M Buy
248,675
+15,233
+7% +$264K 0.22% 87
2022
Q2
$4.07M Hold
233,442
0.18% 93
2022
Q1
$4.88M Buy
233,442
+426
+0.2% +$8.16K 0.21% 83
2021
Q4
$4.14M Buy
233,016
+38,655
+20% +$621K 0.18% 92
2021
Q3
$2.74M Hold
194,361
0.13% 112
2021
Q2
$3.22M Buy
+194,361
New +$3.48M 0.15% 102

Other funds holding NXGN

GW & Wade's NXGN Position: Q4 2023 in Review

GW & Wade sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 296,652 shares — an estimated $7.04M sold.

GW & Wade first reported a position in NXGN in Q2 2021 and held it in 10 quarters. The position peaked at $7.04M in Q3 2023. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.

  • GW & Wade reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • GW & Wade sold 296,652 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $7.04M.
  • GW & Wade first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2021 and held it in 10 quarters.
  • GW & Wade's NextGen Healthcare, Inc. Common Stock position peaked at $7.04M in Q3 2023.
  • 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.

Based on GW & Wade's 13F filing for Q4 2023, filed 8 Feb 2024.